Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by beechguyon Jul 03, 2015 11:40pm
439 Views
Post# 23891336

Financing or buyout / partnership

Financing or buyout / partnershipThere are a lot of people who are convinced a financing is on its way. That is the only logical explanation why we have a .33 sp. Once we have either a financing or partnership happen, our SP will start to trade using a discounted algorithm based on probability of fda success. Until then, this trading is an indication of absolutely nothing. Get on with the financing if you are going this route or partner up. At least this way we can get a realistic valuation based in potential fda approval. If our 500mm peak sales valuation is 2 x revenue, then it should be, with a 50% probability of fda success ( personally think it is closer to 80% as SuJan stated in their seeking alpha article) then the market cap should reflect this, giving us a market cap of 2.50 USD per share. So i expect us to Make it to close to 3 per share before fda decision time is nigh, provided cash is removed from their equation. Bring on the cash berendt. GLTA
<< Previous
Bullboard Posts
Next >>